NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹43 Cr | ₹32 Cr | ₹20 Cr | ₹35 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of NGL FINECHEM ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹43 Cr |
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹35 Cr |
| Mar2022 | ₹14 Cr |
How is Cash Flow from Operating Activities of NGL FINECHEM Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹43 Cr | 33.90 | |
| Mar2025 | ₹32 Cr | 58.07 | |
| Mar2024 | ₹20 Cr | -42.00 | |
| Mar2023 | ₹35 Cr | 155.23 | |
| Mar2022 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,799.6 Cr | -4.7% | -9.7% | 95.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -4.7% |
-9.7% |
95.7% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses